Nanobodies: new avenue to treat kidney disease

Current therapeutic options for renal diseases are limited, and the search for disease-specific treatments is ongoing. Nanobodies, single-domain antibodies with many advantages over conventional antibodies, provide flexible, easy-to-format biologicals with many possible applications. Here, we discus...

Descripción completa

Detalles Bibliográficos
Autores principales: Wanner, Nicola, Eden, Thomas, Liaukouskaya, Nastassia, Koch-Nolte, Friedrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205650/
https://www.ncbi.nlm.nih.gov/pubmed/34131806
http://dx.doi.org/10.1007/s00441-021-03479-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205650/
https://www.ncbi.nlm.nih.gov/pubmed/34131806
http://dx.doi.org/10.1007/s00441-021-03479-8

Ejemplares similares